Upstream Bio, Inc. (UPB) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
UPB currently has 54.3M outstanding shares. with moderate dilution risk from 14.4M authorized shares representing 26.5% potential dilution. The company has minimally diluted shareholders by 1.56% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
10-Q filing | 54.3M shares outstanding |
54M | 14M |
| Mar 26, 2026 |
10-K filing | 53.9M shares outstanding |
54M | 14M |
| Nov 05, 2025 |
10-Q filing | 53.9M shares outstanding |
54M | 14M |
| Aug 06, 2025 |
10-Q filing | 53.8M shares outstanding |
54M | 14M |
| May 06, 2025 |
10-Q filing | 53.6M shares outstanding |
54M | 14M |
| Mar 12, 2025 |
10-K filing | 53.6M shares outstanding |
54M | 14M |
| Nov 07, 2024 |
10-Q filing | 53.6M shares outstanding |
54M | 14M |
| Oct 07, 2024 |
S-1/A filing: Upstream Bio, Inc. is offering 12,500,000 shares of its common stock in an initial public offering. The initial public offering price is expected to be between $15.00 and $17.00 per share. |
N/A | 14M |